These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16567729)

  • 1. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Sanders DB; Aarli JA; Cutter GR; Jaretzki A; Kaminski HJ; Phillips LH
    Neurology; 2006 Mar; 66(6):954-5; author reply 954-5. PubMed ID: 16567729
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
    Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current concept and perspective of immunotherapy for myasthenia gravis: tacrolimus and cyclosporin].
    Yokoyama K
    Nihon Rinsho; 2008 Jun; 66(6):1158-64. PubMed ID: 18540363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis.
    Benatar M; Sanders D
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):945. PubMed ID: 21821871
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus for myasthenia gravis: a clinical study of 212 patients.
    Ponseti JM; Gamez J; Azem J; López-Cano M; Vilallonga R; Armengol M
    Ann N Y Acad Sci; 2008; 1132():254-63. PubMed ID: 18096852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tacrolimus (FK506) in the treatment of prednisone-resistant myasthenia gravis. Preliminary results of 20 cases].
    Ponseti JM; Fort JM; Espin E; Armengol M
    Med Clin (Barc); 2002 Feb; 118(3):117. PubMed ID: 11825555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Corticosteroid therapy in myasthenia gravis: preliminary considerations on the long-term treatment with prednisone].
    Cornelio F; Caraceni T; Negri S
    Riv Neurobiol; 1974; 20(14):78-86. PubMed ID: 4220136
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of tacrolimus in Osserman grade III and Osserman grade IV Myasthenia Gravis.
    Zhao LN; Liang Y; Fang XJ; Liu XM; Jiang QL; Wang SS; She SF; Cao M
    Clin Neurol Neurosurg; 2018 Oct; 173():70-76. PubMed ID: 30092406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients.
    Nagane Y; Suzuki S; Suzuki N; Utsugisawa K
    Eur Neurol; 2010; 64(3):186-90. PubMed ID: 20720424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus.
    Kakisaka Y; Haginoya K; Yokoyama H; Ishitobi M; Wakusawa K; Sato I; Togashi N; Kitamura T; Fukuyo N; Yoshihara Y; Iinuma K
    Brain Dev; 2006 Sep; 28(8):534-6. PubMed ID: 16564661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials for myasthenia gravis: a historical perspective.
    Kaminski HJ; Alnosair E; Algahtani RM
    Ann N Y Acad Sci; 2018 Feb; 1413(1):5-10. PubMed ID: 29377153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myasthenia gravis (3). Corticosteroid therapy of myasthenia gravis].
    Matell G; Osterman PO
    Lakartidningen; 1978 Oct; 75(41):3667-9. PubMed ID: 692233
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.
    Zhang KY; Duan WW; Luo YB; Li Y; Hu J; Yang H
    Orphanet J Rare Dis; 2024 Jan; 19(1):19. PubMed ID: 38243274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of myasthenia gravis with tacrolimus.
    Evoli A; Di Schino C; Marsili F; Punzi C
    Muscle Nerve; 2002 Jan; 25(1):111-4. PubMed ID: 11754194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.
    Wu H; Chen L; Zhou X; Wu Y; Yan Y; Zhu Y; Zhao C; Xue Q
    J Neuroimmunol; 2022 Nov; 372():577955. PubMed ID: 36054935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis.
    Tada M; Shimohata T; Tada M; Oyake M; Igarashi S; Onodera O; Naruse S; Tanaka K; Tsuji S; Nishizawa M
    J Neurol Sci; 2006 Aug; 247(1):17-20. PubMed ID: 16631797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.